Abstract

Aim: This study aimed to determine the occurrence of Burkholderia cepaciae outbreak in neonatal units, identifying the source, defining the best therapy for B. Cepaciae, and enhancing infection control practices. Methods: All neonates with BCC bacteremia during the study period were included. Data were gathered through the microbiology database, medical charts, laboratory data, and infection control surveys. Disk diffusion methodology was used in accordance with CLSI. Information from environmental cultures and feedback was included in the study. Results: The results showed varying patient demographics across the three pediatric wards, with differences in weight, gender distribution, hospital stay duration, and diagnoses. Trends of outbreak were identified with varying patterns in different wards. An intervention was performed, leading to general improvements in infectious disease control practices, and Burkholderia cepaciae was found to be most sensitive to Levofloxacin and Trimethoprim-Sulfamethoxazole. Conclusion: The study identified suspected sources and defined susceptibility profiles for empirical therapy for B. Cepaciae, contributing to the prevention of future outbreaks. Challenges in implementation underscore the need for proper administration and continuous emphasis on correct implementation of infection control practices. Keywords: BCC bacteremia, neonates, outbreak, Burkholderia cepaciae, infection control practices, Civil Hospital Karachi

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.